Target intelligence / Profile preview

Cellular components in Cutibacterium acnes and pilosebaceous unit cells

Molecular classification
Other
01

Overview

The term Cellular components in Cutibacterium acnes and pilosebaceous unit cells refers to the complex biological environment involved in the pathogenesis of acne vulgaris. This system includes the anaerobic bacterium Cutibacterium acnes and the host's pilosebaceous unit, which consists of the hair follicle and its associated sebaceous gland (StatPearls, 2023). C. acnes contributes to disease by secreting proinflammatory mediators and enzymes, such as lipases, which hydrolyze sebum triglycerides into irritating free fatty acids. It also triggers innate immune responses via Toll-like receptors (TLR2 and TLR4) on keratinocytes and sebocytes (PubMed, PMID: 28274357). The host components involve androgen-driven sebum production and hyperkeratinization of the follicular infundibulum, leading to ductal obstruction. Therapeutic agents targeting these components include antibiotics like clindamycin, which inhibit bacterial growth, and retinoids like isotretinoin, which reduce sebum production and normalize cell turnover (NIH, 2023). Because this entry encompasses multiple distinct bacterial and human cellular structures and pathways, it is classified as a composite system rather than a single molecular target.

Other names
Cutibacterium acnes and pilosebaceous unitAcne-associated cellular componentsPropionibacterium acnes and sebaceous gland complex
02

Mechanism of action

Drugs targeting these components act through various mechanisms: antibiotics (e.g., clindamycin) inhibit bacterial protein synthesis; benzoyl peroxide releases reactive oxygen species to kill bacteria; retinoids (e.g., isotretinoin) normalize keratinization and reduce sebum production; and salicylic acid acts as a keratolytic agent.

03

Biological functions

Immune responseInfectionLipid metabolismCell proliferationKeratinization
04

Disease associations

InfectionInflammationAcne vulgaris
05

Safety considerations

Antibiotic resistanceSkin irritationPhotosensitivityTeratogenicity (associated with systemic retinoids)Dryness and peeling
06

Interacting drugs

Benzoyl peroxide

8 more in the full profile.

07

Biomarkers

Cutibacterium acnes colonization densitySebum excretion rateInflammatory cytokine levels (e.g., IL-1 alpha, TNF-alpha)Lesion count

Beyond the preview

Go deeper on Cellular components in Cutibacterium acnes and pilosebaceous unit cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular components in Cutibacterium acnes and pilosebaceous unit cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call